These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8393918)

  • 1. Antiviral effect of short hyperthermic treatment at specific stages of vesicular stomatitis virus replication cycle.
    De Marco A; Santoro MG
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1685-90. PubMed ID: 8393918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combined alpha IFN and prostaglandin A1 treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells.
    Pica F; Rossi A; Santirocco N; Palamara A; Garaci E; Santoro MG
    Antiviral Res; 1996 Mar; 29(2-3):187-98. PubMed ID: 8739598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of vesicular stomatitis virus replication by delta 12-prostaglandin J2 is regulated at two separate levels and is associated with induction of stress protein synthesis.
    Pica F; De Marco A; De Cesare F; Santoro MG
    Antiviral Res; 1993 Mar; 20(3):193-208. PubMed ID: 8385894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of vesicular stomatitis virus replication by prostaglandin A1 in Aedes albopictus cells.
    Burlandy FM; Ferreira DF; Rebello MA
    Z Naturforsch C J Biosci; 2004; 59(1-2):127-31. PubMed ID: 15018065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of virus replication by prostaglandin A is associated with heat shock protein synthesis.
    Amici C; Santoro MG
    J Gen Virol; 1991 Aug; 72 ( Pt 8)():1877-85. PubMed ID: 1651981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin A inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein.
    Santoro MG; Jaffe BM; Esteban M
    J Gen Virol; 1983 Dec; 64 ( Pt 12)():2797-801. PubMed ID: 6198441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicular stomatitis virus induces apoptosis at early stages in the viral cycle and does not depend on virus replication.
    Gadaleta P; Vacotto M; Coulombié F
    Virus Res; 2002 Jun; 86(1-2):87-92. PubMed ID: 12076832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells.
    Dargan DJ; Galt CB; Subak-Sharpe JH
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral effect of hyperthermic treatment in rhinovirus infection.
    Conti C; De Marco A; Mastromarino P; Tomao P; Santoro MG
    Antimicrob Agents Chemother; 1999 Apr; 43(4):822-9. PubMed ID: 10103186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
    Trottier MD; Palian BM; Reiss CS
    Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of vesicular stomatitis virus replication by epidermal growth factor in human epidermoid A-431 cells.
    Korutla L; Kumar R
    Biochem Biophys Res Commun; 1996 Mar; 220(3):670-4. PubMed ID: 8607823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral effect of cyclopentenone prostaglandins on vesicular stomatitis virus replication.
    Parker J; Ahrens PB; Ankel H
    Antiviral Res; 1995 Jan; 26(1):83-96. PubMed ID: 7537950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD).
    Zhang XM; He DN; Zhou B; Pang R; Liu K; Zhao J; Chen PY
    Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. the influence of the host cell on the inhibition of virus protein synthesis in cells double infected with vesicular stomatitis virus and mengovirus.
    Otto MJ; Lucas-Lenard J
    J Gen Virol; 1980 Oct; 50(2):293-307. PubMed ID: 6257824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lauric acid inhibits the maturation of vesicular stomatitis virus.
    Hornung B; Amtmann E; Sauer G
    J Gen Virol; 1994 Feb; 75 ( Pt 2)():353-61. PubMed ID: 8113756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hsp70-dependent antiviral immunity against cytopathic neuronal infection by vesicular stomatitis virus.
    Kim MY; Ma Y; Zhang Y; Li J; Shu Y; Oglesbee M
    J Virol; 2013 Oct; 87(19):10668-78. PubMed ID: 23885078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vesicular stomatitis virus replication in dexamethasone-treated L929 cells.
    Lancz G; Whitaker-Dowling P; Marsh YV; Bradley G; Eppstein DA; Hackney JF; Hulick-Swardstrom B
    Proc Soc Exp Biol Med; 1990 Mar; 193(3):190-6. PubMed ID: 2154755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of stress proteins in Sindbis virus- and vesicular stomatitis virus-infected cells.
    Garry RF; Ulug ET; Bose HR
    Virology; 1983 Sep; 129(2):319-32. PubMed ID: 6312678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of poliovirus replication by prostaglandins A and J in human cells.
    Conti C; Mastromarino P; Tomao P; De Marco A; Pica F; Santoro MG
    Antimicrob Agents Chemother; 1996 Feb; 40(2):367-72. PubMed ID: 8834882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
    Ahmed M; Cramer SD; Lyles DS
    Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.